Literature DB >> 47417

Rubella-specific serum and nasopharygeal immunoglobulin responses following naturally acquired and vaccine-induced infection. Prolonged persistence of virus-specific IgM.

W Al-Nakib, J M Best, J E Banatvala.   

Abstract

Rubella-specific immunoglobulin responses in sera and nasopharyngeal secretions were compared in groups of adult females who had experienced naturally acquired rubella or infection induced by Cendehill, HPV77.DE-5, RA27/3 (subcutaneously and intranasally), and To-336 vaccines. Serum IgG and IgA and nasopharyngeal IgA responses after vaccination by RA27/3 intranasally most closely resembled those induced by naturally acquired infection. However, the other vaccines failed to induce a persistent local IgA response. Levels of local antibody induced by HPV77.DE-5 were especially poor. Virus-specific IgM was detected for prolonged periods. The highest levels and the most persistent response followed vaccination by HPV77.DE-5, four of five volunteers still having rubella-specific IgM at 1 year. Virus-specific IgM persisted for 6 months in seventeen of twenty-five (68%) and for a year in nine of twenty-four (38%) vaccinees. It was still present in four of nine (44%) naturally infected patients at a year.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 47417     DOI: 10.1016/s0140-6736(75)91356-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  19 in total

1.  Epstein-Barr virus-specific serum immunoglobulin A as an acute-phase antibody in infectious mononucleosis.

Authors:  J Nikoskelainen; E U Neel; D A Stevens
Journal:  J Clin Microbiol       Date:  1979-07       Impact factor: 5.948

2.  Humoral immune response after primary rubella virus infection and after vaccination.

Authors:  C Vauloup-Fellous; L Grangeot-Keros
Journal:  Clin Vaccine Immunol       Date:  2007-03-07

3.  The administration of drugs and vaccines by the intranasal route.

Authors:  D S Freestone; A L Weinberg
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

4.  Specific immunoglobulin responses after varicella and herpes zoster.

Authors:  J E Cradock-Watson; M K Ridehalgh; M S Bourne
Journal:  J Hyg (Lond)       Date:  1979-04

5.  Clinical evaluation of the sensitivity and specificity of a commercially available enzyme immunoassay for detection of rubella virus-specific immunoglobulin M.

Authors:  M A Chernesky; L Wyman; J B Mahony; S Castriciano; J T Unger; J W Safford; P S Metzel
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

6.  IgA antibody response in acute rubella determined by solid-phase radioimmunoassay.

Authors:  P Halonen; O Meurman; M T Matikainen; E Torfason; H Bennich
Journal:  J Hyg (Lond)       Date:  1979-08

7.  Detection of rubella-specific serum IgG and IgA and nasopharyngeal IgA responses using a radioactive single radial immunodiffusion technique.

Authors:  W Al-Nakib; J M Best; J E Banatvala
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

8.  Persistence of immunoglobulin G and immunoglobulin M antibodies after postnatal rubella infection determined by solid-phase radioimmunoassay.

Authors:  O H Meurman
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

9.  BK antibody and virus-specific IgM responses in renal transplant recipients, patients with malignant disease, and healthy people.

Authors:  A J Flower; J E Banatvala; I L Chrystie
Journal:  Br Med J       Date:  1977-07-23

10.  Rubella-specific immune complexes after congenital infection and vaccination.

Authors:  P K Coyle; J S Wolinsky; E Buimovici-Klein; R Moucha; L Z Cooper
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.